Medicare Rx Benefit "More Significant" Than Waxman/Hatch Reform - Barr

Enactment of a Medicare prescription drug benefit is a higher priority for generic drug companies than reforms to the Waxman/Hatch Act, Barr CEO Bruce Downey told analysts Aug. 7.